Back
Alnylam Pharmaceuticals Vs. Alimera Sciences Industry Stock Comparison
Buy
61
ALNY
Alnylam Pharmaceuticals
Last Price:
243.28
Seasonality Move:
15.98%
Buy
94
ALIM
Alimera Sciences
Last Price:
5.52
Seasonality Move:
-11.98%
Buy
61
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.32. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
94
Alimera Sciences (ALIM)
is a Buy
Is Alimera Sciences a Buy, Sell or Hold?
- The current Alimera Sciences [ALIM] share price is $5.52. The Score for ALIM is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- ALIM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
ALIM Stock Price Chart
What is Alimera Sciences's stock price today?
-
The Alimera Sciences share price today is $5.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALIM is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.3 | Buy |
| Relative Strength Index (14 RSI): | 86.74 | Buy |
| Chaikin Money Flow: | 174062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.09 - 211.95) | Buy |
| Bollinger Bands (100): | (135.42 - 179.08) | Buy |
ALIM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 82.47 | Buy |
| Chaikin Money Flow: | -260426 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.59 - 4.71) | Buy |
| Bollinger Bands (100): | (3.06 - 4.22) | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.62 | Buy |
| 20-day SMA: | 180.99 | Buy |
| 50-day SMA: | 161.59 | Buy |
| 200-day SMA: | 166.12 | Buy |
| 8-day EMA: | 223.64 | Buy |
| 20-day EMA: | 193.95 | Buy |
| 50-day EMA: | 171.81 | Buy |
| 200-day EMA: | 168.84 | Buy |
ALIM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.92 | Buy |
| 20-day SMA: | 3.8 | Buy |
| 50-day SMA: | 3.54 | Buy |
| 200-day SMA: | 3.56 | Buy |
| 8-day EMA: | 4.99 | Buy |
| 20-day EMA: | 4.21 | Buy |
| 50-day EMA: | 3.76 | Buy |
| 200-day EMA: | 3.57 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Alimera Sciences Earnings Growth & ALIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.24 per share.
Alnylam Pharmaceuticals Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alimera Sciences Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||